Sam Yang Foods (003230)
Korea Exchange · Korea · prices in KRW · close of 27 Oct 2026
Key indicators
| Last close | KRW 1,133,000.00 |
|---|---|
| 52-week range | 981,000.00 – 1,557,000.00 |
| Return, 1 month / 3 months | −6.7% / −6.9% |
| Return, 1 year / 3 years | −9.7% / +530.8% |
| Trend | Below its 200-day average |
| RSI (14) | 39 |
| Volatility (1 year) | 52.1% |
| Worst drawdown (1 year) | -29.7% |
| Average daily value traded | 68,545.91M KRW |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sam Yang Foods is a Korean food company that makes instant noodles, known in Korea as ramyun, along with other packaged foods and snacks. Its products include the Samyang Ramen brand and the spicy Buldak chicken flavour noodle line, which it exports to customers in many countries. The company is based in Seoul, Korea, and its noodles are sold through grocery stores and food retailers at home and abroad.
Sam Yang Foods trades under the code 003230 on the Korea Exchange in Korea, with its price quoted in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sam Yang Foods (003230) trades on the Korea Exchange in Korea. It last closed at KRW 1,133,000.00 on 27 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 128 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.7% and over the last three months it fell 6.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 79 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -6.8% | ||
| From 52-week high | -26.8% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -6.9% | ||
| 6-month return | -12.7% | ||
| 12-month return, skipping the last month | -3.2% | ||
| Stability (higher is calmer) | 64 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 52.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.7% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 68,545.91M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −7.2% |
|---|---|
| 1 month | −6.7% |
| 3 months | −6.9% |
| 6 months | −12.7% |
| 1 year | −9.7% |
| 3 years | +530.8% |
| 5 years | +1,319.3% |
Signals
| 50-day / 200-day average | 1,287,706.16 / 1,216,081.17 |
|---|---|
| Golden / death cross (60 days) | Golden, 34 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 56,934.58 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Aug 2026 | KRW 3,200.0000 |
| 26 Feb 2026 | KRW 2,600.0000 |
| 26 Aug 2025 | KRW 2,200.0000 |
| 27 Feb 2025 | KRW 1,800.0000 |
| 26 Aug 2024 | KRW 1,500.0000 |
| 27 Dec 2023 | KRW 1,100.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.